HUP0300054A1 - Daganatspecifikus állati fehérjék - Google Patents
Daganatspecifikus állati fehérjékInfo
- Publication number
- HUP0300054A1 HUP0300054A1 HU0300054A HUP0300054A HUP0300054A1 HU P0300054 A1 HUP0300054 A1 HU P0300054A1 HU 0300054 A HU0300054 A HU 0300054A HU P0300054 A HUP0300054 A HU P0300054A HU P0300054 A1 HUP0300054 A1 HU P0300054A1
- Authority
- HU
- Hungary
- Prior art keywords
- tumour
- animal proteins
- specific animal
- polypeptides
- polynucleotides
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 235000021120 animal protein Nutrition 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A találmány tárgyát CASB7439 polipeptidek és polinukleotidok, azokattartalmazó immunogén készítmények, és ilyen polipeptidek rekombinánsmódszerekkel történő előállítására alkalmas eljárások képezik. Atalálmány tárgyát képezik továbbá eljárások CASB7439 polipeptidek éspolinukleotidok alkalmazására szolgáló diagnosztikai eljárások, ésoltóanyagok rák, különösen kolorektális rák, autoimmun betegségek éskapcsolódó állapotok profilaktikus és terápiás kezelésére. Ó
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0004269A GB0004269D0 (en) | 2000-02-23 | 2000-02-23 | Novel compounds |
GB0009905A GB0009905D0 (en) | 2000-04-20 | 2000-04-20 | Novel compounds |
GB0021080A GB0021080D0 (en) | 2000-08-25 | 2000-08-25 | Novel compounds |
PCT/EP2001/001779 WO2001062778A2 (en) | 2000-02-23 | 2001-02-16 | Tumour-specific animal proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300054A1 true HUP0300054A1 (hu) | 2003-05-28 |
HUP0300054A3 HUP0300054A3 (en) | 2012-09-28 |
Family
ID=27255552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300054A HUP0300054A3 (en) | 2000-02-23 | 2001-02-16 | Tumour-specific animal proteins |
Country Status (24)
Country | Link |
---|---|
US (5) | US20030157118A1 (hu) |
EP (2) | EP1650221B1 (hu) |
JP (1) | JP5502253B2 (hu) |
KR (3) | KR100919916B1 (hu) |
CN (1) | CN1254541C (hu) |
AT (1) | ATE487733T1 (hu) |
AU (3) | AU5615601A (hu) |
BR (1) | BR0108654A (hu) |
CA (1) | CA2400842C (hu) |
CY (2) | CY1111156T1 (hu) |
CZ (1) | CZ303468B6 (hu) |
DE (1) | DE60143425D1 (hu) |
DK (2) | DK1265915T3 (hu) |
ES (1) | ES2389445T3 (hu) |
HK (2) | HK1093513A1 (hu) |
HU (1) | HUP0300054A3 (hu) |
IL (2) | IL151097A0 (hu) |
MX (1) | MXPA02008279A (hu) |
NO (1) | NO332141B1 (hu) |
NZ (1) | NZ520673A (hu) |
PL (1) | PL209127B1 (hu) |
PT (2) | PT1650221E (hu) |
SI (2) | SI1265915T1 (hu) |
WO (1) | WO2001062778A2 (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1650221E (pt) * | 2000-02-23 | 2012-09-05 | Glaxosmithkline Biolog Sa | Novos compostos |
DK1889630T3 (da) * | 2000-10-18 | 2012-03-05 | Glaxosmithkline Biolog Sa | Vacciner omfattende MAGE-antigen koblet til protein D-fragment |
WO2002061085A2 (en) | 2000-10-31 | 2002-08-08 | Ryan James W | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
GB0100756D0 (en) | 2001-01-11 | 2001-02-21 | Powderject Res Ltd | Needleless syringe |
GB0111974D0 (en) * | 2001-05-16 | 2001-07-04 | Glaxosmithkline Biolog Sa | Novel Compounds |
EP1575515A4 (en) * | 2002-08-29 | 2007-08-08 | Genentech Inc | ACHAETE-SCUTE-SIMILAR 2 POLYPEPTIDES AND CODING NUCLEIC ACIDS AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF A TUMOR |
CN1310033C (zh) * | 2004-03-23 | 2007-04-11 | 中国医学科学院肿瘤医院肿瘤研究所 | 一种检测血清蛋白指纹的新方法 |
CA2653949A1 (en) | 2006-06-02 | 2007-12-13 | Glaxosmithkline Biologicals S.A. | Method |
GB0708758D0 (en) | 2007-05-04 | 2007-06-13 | Powderject Res Ltd | Particle cassettes and process thereof |
JP5331105B2 (ja) | 2007-05-24 | 2013-10-30 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 凍結乾燥抗原組成物 |
AU2010252012A1 (en) | 2009-05-27 | 2011-12-22 | Glaxosmithkline Biologicals S.A. | CASB7439 constructs |
GB0917457D0 (en) | 2009-10-06 | 2009-11-18 | Glaxosmithkline Biolog Sa | Method |
US20110129574A1 (en) * | 2009-11-30 | 2011-06-02 | Pathak Chandrashekhar P | Methods and compositions for filling fleshy fruits and vegetables |
EP4176871A1 (en) * | 2011-10-03 | 2023-05-10 | Canqura Oncology Ab | Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds |
GB201520592D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
US10422675B2 (en) | 2017-06-09 | 2019-09-24 | Aps Technology, Inc. | System and method for monitoring mud flow in a component of drilling system |
Family Cites Families (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
US4372945A (en) | 1979-11-13 | 1983-02-08 | Likhite Vilas V | Antigen compounds |
IL61904A (en) | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
US4866034A (en) | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
US4877611A (en) | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US5811128A (en) | 1986-10-24 | 1998-09-22 | Southern Research Institute | Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor |
GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
DE10399032I1 (de) | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
WO1989001973A2 (en) | 1987-09-02 | 1989-03-09 | Applied Biotechnology, Inc. | Recombinant pox virus for immunization against tumor-associated antigens |
AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
US5549910A (en) | 1989-03-31 | 1996-08-27 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
ATE133087T1 (de) | 1989-05-04 | 1996-02-15 | Southern Res Inst | Einkapselungsverfahren |
US5725871A (en) | 1989-08-18 | 1998-03-10 | Danbiosyst Uk Limited | Drug delivery compositions comprising lysophosphoglycerolipid |
EP0487587A1 (en) | 1989-08-18 | 1992-06-03 | Chiron Corporation | Recombinant retroviruses delivering vector constructs to target cells |
KR920007887B1 (ko) | 1989-08-29 | 1992-09-18 | 스즈키 지도오샤 고오교오 가부시키가이샤 | 내연기관의 배기가스 정화장치 |
NZ235315A (en) | 1989-09-19 | 1991-09-25 | Wellcome Found | Chimaeric hepadnavirus core antigen proteins and their construction |
US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
DE69031951T2 (de) | 1989-11-16 | 1998-08-13 | Du Pont | Transformation von tierischen Hautzellen mit hilfe von Partikeln |
FR2658432B1 (fr) | 1990-02-22 | 1994-07-01 | Medgenix Group Sa | Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation. |
US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
AU8200191A (en) | 1990-07-09 | 1992-02-04 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
JP3218637B2 (ja) | 1990-07-26 | 2001-10-15 | 大正製薬株式会社 | 安定なリポソーム水懸濁液 |
MY109299A (en) | 1990-08-15 | 1996-12-31 | Virogenetics Corp | Recombinant pox virus encoding flaviviral structural proteins |
JP2958076B2 (ja) | 1990-08-27 | 1999-10-06 | 株式会社ビタミン研究所 | 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法 |
GB9022190D0 (en) | 1990-10-12 | 1990-11-28 | Perham Richard N | Immunogenic material |
US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
JP3534749B2 (ja) | 1991-08-20 | 2004-06-07 | アメリカ合衆国 | アデノウイルスが介在する胃腸管への遺伝子の輸送 |
US5756353A (en) | 1991-12-17 | 1998-05-26 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol-and liposome-based delivery |
MX9300883A (es) * | 1992-02-18 | 1994-08-31 | Smithkline Beecham Corp | Polipeptidos de vacuna. |
ES2105262T3 (es) | 1992-05-18 | 1997-10-16 | Minnesota Mining & Mfg | Dispositivo de suministro de farmaco a traves de las mucosas. |
US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
PT761231E (pt) | 1992-06-25 | 2000-06-30 | Smithkline Beecham Biolog | Composicao de vacina contendo adjuvantes |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
EP0678034B1 (en) | 1993-01-11 | 1999-05-26 | Dana Farber Cancer Institute | Inducing cytotoxic t lymphocyte responses |
US5654186A (en) | 1993-02-26 | 1997-08-05 | The Picower Institute For Medical Research | Blood-borne mesenchymal cells |
FR2702160B1 (fr) | 1993-03-02 | 1995-06-02 | Biovecteurs As | Vecteurs particulaires synthétiques et procédé de préparation. |
CA2160011A1 (en) | 1993-04-06 | 1994-10-13 | Philip D. Greenberg | Chimeric cytokine receptors in lymphocytes |
FR2704145B1 (fr) | 1993-04-21 | 1995-07-21 | Pasteur Institut | Vecteur particulaire et composition pharmaceutique le contenant. |
WO1994029458A1 (en) | 1993-06-07 | 1994-12-22 | Amgen Inc. | Hybrid receptor molecules |
US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
CA2153480A1 (en) | 1993-11-12 | 1995-06-01 | Kenichi Matsubara | Gene signature |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
AU674815B2 (en) | 1994-01-21 | 1997-01-09 | Powderject Vaccines, Inc. | Gas driven gene delivery instrument |
US5505947A (en) | 1994-05-27 | 1996-04-09 | The University Of North Carolina At Chapel Hill | Attenuating mutations in Venezuelan Equine Encephalitis virus |
US6194388B1 (en) | 1994-07-15 | 2001-02-27 | The University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
FR2723849B1 (fr) | 1994-08-31 | 1997-04-11 | Biovector Therapeutics Sa | Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique |
US5795587A (en) | 1995-01-23 | 1998-08-18 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
GB9502879D0 (en) | 1995-02-14 | 1995-04-05 | Oxford Biosciences Ltd | Particle delivery |
US5580579A (en) | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
US5738868A (en) | 1995-07-18 | 1998-04-14 | Lipogenics Ltd. | Liposome compositions and kits therefor |
EP0871747A1 (en) | 1996-01-02 | 1998-10-21 | Chiron Viagene, Inc. | Immunostimulation mediated by gene-modified dendritic cells |
DE69738597T2 (de) * | 1996-02-09 | 2008-07-24 | Glaxosmithkline Biologicals S.A. | Vakzine gegen das varicella zostervirus produkt von gen 63 |
US5776683A (en) | 1996-07-11 | 1998-07-07 | California Pacific Medical Center | Methods for identifying genes amplified in cancer cells |
US5856462A (en) | 1996-09-10 | 1999-01-05 | Hybridon Incorporated | Oligonucleotides having modified CpG dinucleosides |
US5811407A (en) | 1997-02-19 | 1998-09-22 | The University Of North Carolina At Chapel Hill | System for the in vivo delivery and expression of heterologous genes in the bone marrow |
US6355257B1 (en) | 1997-05-08 | 2002-03-12 | Corixa Corporation | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
GB9727262D0 (en) | 1997-12-24 | 1998-02-25 | Smithkline Beecham Biolog | Vaccine |
DK1659179T3 (da) * | 1998-02-05 | 2011-10-10 | Glaxosmithkline Biolog Sa | Tumor-associerede antigenderivater fra MAGE-familien og nucleinsyresekvenser kodende for dem anvendt til fremstilling af fusionsproteiner og sammensætninger til vaccination |
DK1054689T3 (da) | 1998-02-12 | 2004-01-26 | Apovia Inc | Strategisk modificerede hepatitis B-kerneproteiner og derivater deraf |
US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
CA2324289C (en) | 1998-03-09 | 2010-07-13 | Smithkline Beecham Biologicals S.A. | Combined vaccine compositions |
BR9909915A (pt) | 1998-04-09 | 2000-12-26 | Smithkline Beecham Biolog | Composições adjuvantes |
AU773204C (en) | 1998-08-10 | 2005-05-19 | Antigenics Llc | Compositions of CPG and saponin adjuvants and methods thereof |
US6087168A (en) * | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
ATE342727T1 (de) * | 1999-03-11 | 2006-11-15 | Glaxosmithkline Biolog Sa | Verwendung von casb618 polynucleotide und polypeptide |
AU5788900A (en) | 1999-07-07 | 2001-01-22 | Tularik Inc. | Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides |
AU2001236589A1 (en) | 2000-02-04 | 2001-08-14 | Aeomica, Inc. | Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes |
US7811574B2 (en) * | 2000-02-23 | 2010-10-12 | Glaxosmithkline Biologicals S.A. | Tumour-specific animal proteins |
PT1650221E (pt) * | 2000-02-23 | 2012-09-05 | Glaxosmithkline Biolog Sa | Novos compostos |
WO2002061085A2 (en) * | 2000-10-31 | 2002-08-08 | Ryan James W | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
EP1575515A4 (en) | 2002-08-29 | 2007-08-08 | Genentech Inc | ACHAETE-SCUTE-SIMILAR 2 POLYPEPTIDES AND CODING NUCLEIC ACIDS AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF A TUMOR |
AU2010252012A1 (en) | 2009-05-27 | 2011-12-22 | Glaxosmithkline Biologicals S.A. | CASB7439 constructs |
-
2001
- 2001-02-16 PT PT06075141T patent/PT1650221E/pt unknown
- 2001-02-16 KR KR1020087004445A patent/KR100919916B1/ko not_active IP Right Cessation
- 2001-02-16 IL IL15109701A patent/IL151097A0/xx unknown
- 2001-02-16 ES ES06075141T patent/ES2389445T3/es not_active Expired - Lifetime
- 2001-02-16 AT AT01929345T patent/ATE487733T1/de active
- 2001-02-16 BR BR0108654-5A patent/BR0108654A/pt not_active IP Right Cessation
- 2001-02-16 CA CA2400842A patent/CA2400842C/en not_active Expired - Fee Related
- 2001-02-16 JP JP2001562559A patent/JP5502253B2/ja not_active Expired - Fee Related
- 2001-02-16 SI SI200130986T patent/SI1265915T1/sl unknown
- 2001-02-16 PT PT01929345T patent/PT1265915E/pt unknown
- 2001-02-16 EP EP06075141A patent/EP1650221B1/en not_active Expired - Lifetime
- 2001-02-16 DK DK01929345.5T patent/DK1265915T3/da active
- 2001-02-16 DK DK06075141.9T patent/DK1650221T3/da active
- 2001-02-16 CZ CZ20022874A patent/CZ303468B6/cs not_active IP Right Cessation
- 2001-02-16 CN CNB018084117A patent/CN1254541C/zh not_active Expired - Fee Related
- 2001-02-16 KR KR1020027010961A patent/KR100848973B1/ko not_active IP Right Cessation
- 2001-02-16 WO PCT/EP2001/001779 patent/WO2001062778A2/en active IP Right Grant
- 2001-02-16 PL PL362698A patent/PL209127B1/pl unknown
- 2001-02-16 DE DE60143425T patent/DE60143425D1/de not_active Expired - Lifetime
- 2001-02-16 KR KR1020097013427A patent/KR20090085697A/ko not_active Application Discontinuation
- 2001-02-16 MX MXPA02008279A patent/MXPA02008279A/es active IP Right Grant
- 2001-02-16 SI SI200131014T patent/SI1650221T1/sl unknown
- 2001-02-16 AU AU5615601A patent/AU5615601A/xx active Pending
- 2001-02-16 NZ NZ520673A patent/NZ520673A/en not_active IP Right Cessation
- 2001-02-16 AU AU2001256156A patent/AU2001256156B2/en not_active Ceased
- 2001-02-16 HU HU0300054A patent/HUP0300054A3/hu unknown
- 2001-02-16 EP EP01929345A patent/EP1265915B1/en not_active Expired - Lifetime
-
2002
- 2002-08-06 IL IL151097A patent/IL151097A/en not_active IP Right Cessation
- 2002-08-22 NO NO20024002A patent/NO332141B1/no not_active IP Right Cessation
- 2002-08-23 US US10/226,872 patent/US20030157118A1/en not_active Abandoned
-
2003
- 2003-05-22 HK HK06111131.1A patent/HK1093513A1/xx not_active IP Right Cessation
- 2003-05-22 HK HK03103646.9A patent/HK1052710A1/xx not_active IP Right Cessation
-
2005
- 2005-12-13 US US11/301,895 patent/US7803379B2/en not_active Expired - Fee Related
-
2006
- 2006-03-10 AU AU2006201042A patent/AU2006201042B2/en not_active Ceased
-
2009
- 2009-03-09 US US12/400,449 patent/US20100291121A1/en not_active Abandoned
-
2010
- 2010-08-20 US US12/860,020 patent/US8207123B2/en not_active Expired - Fee Related
-
2011
- 2011-01-28 CY CY20111100086T patent/CY1111156T1/el unknown
-
2012
- 2012-05-15 US US13/472,035 patent/US8535690B2/en not_active Expired - Fee Related
- 2012-09-12 CY CY20121100829T patent/CY1113109T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300054A1 (hu) | Daganatspecifikus állati fehérjék | |
HUP0203968A2 (hu) | Készítmények és eljárások prosztatarák terápiájára és diagnózisára | |
HUP0203035A2 (hu) | Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások | |
TR200102577T2 (tr) | Kanser Tedavisi için Casb616 Polipeptid ve Polinücleotidlerin kullanımı | |
AU2003242305A1 (en) | Hla-a24-restricted cancer antigen peptide | |
NO20004631D0 (no) | Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft | |
HUP0302824A2 (hu) | Vakcinakészítmények | |
DE69435075D1 (de) | , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
NZ330887A (en) | Monoclonals and polyclonals antibodies for the diagnosis of breast cancer | |
HUP0302532A2 (hu) | Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások | |
IL145731A0 (en) | A polypetide containing an immunogenic portion of a breast tumor protein and pharmaceutical compositions containing the same | |
NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
HUP0301740A2 (hu) | Emlőrák kezelésére és diagnosztizálására szolgáló készítmények és eljárások | |
HUP0302965A2 (hu) | Vakcina | |
WO1998045328A3 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
WO2002088750A3 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
WO2000061756A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
WO2001071357A3 (en) | Diagnosis and treatment of breast cancer | |
HUP0402071A2 (hu) | Csökkentett immunogenitású, módosított leptin | |
ATE514780T1 (de) | Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon | |
IL207012A (en) | 28sgp medicinal product and 28sgp accent cancer treatment vaccine | |
HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására | |
HUP0400340A2 (hu) | Polipeptidek immunogenitásának csökkentésére szolgáló eljárások | |
MXPA01010186A (es) | Composiciones y metodos para el tratamiento y diagnostico de cancer de mama. | |
BR0008917A (pt) | Compostos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |